Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias



Status:Recruiting
Conditions:Atrial Fibrillation, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - 70
Updated:4/21/2016
Start Date:June 2013
End Date:February 2016
Contact:Evgeny Pokushalov, MD, PhD
Email:e.pokushalov@gmail.com
Phone:+79139254858

Use our guide to learn which trials are right for you!

The investigators have conducted a prospective, double-blind, randomized study to assess the
comparative safety and efficacy of two different ablation strategies, RFA versus RFA plus
botulinum toxin injection, in patients with supra-ventricular tachyarrhythmias. Results were
assessed with the use of an implanted monitoring device (IMD).


Inclusion Criteria:

- atrial flutter, AV nodal re-entry tachycardia, focal atrial tachycardia, WPW syndrome

- secondary atrial fibrillation

Exclusion Criteria:

- congestive heart failure

- LV ejection fraction < 35%

- left atrial diameter > 60 mm
We found this trial at
2
sites
Novosibirsk, 63005
Principal Investigator: Evgeny Pokushalov, MD, PhD
Phone: +79139254858
?
mi
from
Novosibirsk,
Click here to add this to my saved trials
60 Crittenden Blvd # 70
Rochester, New York 14642
(585) 275-2121
University of Rochester The University of Rochester is one of the country's top-tier research universities....
?
mi
from
Rochester, NY
Click here to add this to my saved trials